Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-01-12 @ 7:36 PM
Study NCT ID:
NCT03300505
Status:
TERMINATED
Last Update Posted:
2025-05-13
First Post:
2017-09-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UMCC 2017.055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |